4.8 Article

PreS/2-21-Guided siRNA Nanoparticles Target to Inhibit Hepatitis B Virus Infection and Replication

Related references

Note: Only part of the references are listed.
Article Virology

Immunostimulatory siRNA with a uridine bulge leads to potent inhibition of HBV and activation of innate immunity

Tingyu Lan et al.

Summary: The study found that msiHBx can effectively inhibit HBV expression and replication, induce an antiviral innate immune response without proinflammatory activation. The dual RNAi and immunostimulatory activity of msiRNAs may play an important role in the control of HBV infection.

VIROLOGY JOURNAL (2021)

Review Biology

siRNA therapeutics: a clinical reality

Phei Er Saw et al.

SCIENCE CHINA-LIFE SCIENCES (2020)

Article Nanoscience & Nanotechnology

Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy

Yazhe Wang et al.

ACS APPLIED MATERIALS & INTERFACES (2020)

Review Virology

The Interactions Between HBV and the Innate Immunity of Hepatocytes

Fayed Attia Koutb Megahed et al.

VIRUSES-BASEL (2020)

Editorial Material Chemistry, Medicinal

New Chemical Modalities and Strategic Thinking in Early Drug Discovery

Maria-Jesus Blanco et al.

ACS MEDICINAL CHEMISTRY LETTERS (2020)

Article Biochemistry & Molecular Biology

Generation and validation of structurally defined antibody-siRNA conjugates

Alex R. Nanna et al.

NUCLEIC ACIDS RESEARCH (2020)

Review Gastroenterology & Hepatology

Hepatitis B Current Status of Therapy and Future Therapies

Elias Spyrou et al.

GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2020)

Article Medicine, General & Internal

Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria

Eliane Sardh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Virology

Spatiotemporal Analysis of Hepatitis B Virus X Protein in Primary Human Hepatocytes

Dmytro Kornyeyev et al.

JOURNAL OF VIROLOGY (2019)

Article Gastroenterology & Hepatology

A global scientific strategy to cure hepatitis B

Peter A. Revill et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

The antiviral effects of human microRNA miR-302c-3p against hepatitis B virus infection

Susumu Hamada-Tsutsumi et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Review Chemistry, Medicinal

2018 FDA Tides Harvest

Danah Al Shaer et al.

PHARMACEUTICALS (2019)

Review Virology

A review on current status of antiviral siRNA

Abid Qureshi et al.

REVIEWS IN MEDICAL VIROLOGY (2018)

Article Virology

Role of HBx in hepatitis B virus persistence and its therapeutic implications

Betty L. Slagle et al.

CURRENT OPINION IN VIROLOGY (2018)

Article Pharmacology & Pharmacy

New antivirals for the treatment of chronic hepatitis B

Vincent Soriano et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)

Article Gastroenterology & Hepatology

Future anti-HBV strategies

Edward J. Gane

LIVER INTERNATIONAL (2017)

Article Biochemistry & Molecular Biology

Modified mRNA Vaccines Protect against Zika Virus Infection

Justin M. Richner et al.

Review Gastroenterology & Hepatology

Hepatitis B virus therapy: What's the future holding for us?

Sobia Manzoor et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Review Gastroenterology & Hepatology

From DCPD to NTCP: The long journey towards identifying a functional hepatitis B virus receptor

Jisu Li et al.

CLINICAL AND MOLECULAR HEPATOLOGY (2015)

Article Gastroenterology & Hepatology

Targeted delivery of siRNA against hepatitis B virus by preS1 peptide molecular ligand

Wenjuan Huang et al.

HEPATOLOGY RESEARCH (2014)

Review Biochemistry & Molecular Biology

NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry

Koichi Watashi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)

Article Biochemistry & Molecular Biology

Targeted screening of siRNA directed HBV polymerase gene for effective inhibition of HBV expression

Jinjian Yao et al.

JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2008)

Article Gastroenterology & Hepatology

Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA

C Klein et al.

GASTROENTEROLOGY (2003)

Article Pharmacology & Pharmacy

Chemotherapy with hybrid liposomes without any drug in vivo

H Ichihara et al.

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2003)